Some Guest Lecturers Bill Abernethy, Director, Global Marketing, Genzyme Fidah Alsagoff, Director, Corporate Development, Singapore Health Services Jean-Claude Ameisen, Director of the INSERM Ethics Committee Laurent Bertin, Vice-President, Prospective and Portfolio Management, sanofi-aventis Alan Colman, Chief Executive Officer, Embryonic Stem Cell International Marc de Garidel, Vice-President Southwest Europe, Amgen International Hervé Gisserot, Chief Executive Officer, GlaxoSmithKline France Marlene Haffner, Director, Office of Orphan Products Development, FDA Damian Hine, Professor of Management, University of Queensland, Australia Michèle Jean, Chairman of the International Bioethics Committee, UNESCO Claudio Jommi, Head of the Osservatorio Farmaci, Bocconi University Axel Kahn, Dean of Paris-Descartes University Evelyn Fox Keller, Professor of epistemology, Massachusetts Institute of Technology Philippe Kourilsky, Professor at the Collège de France Christian Lajoux, Chief Executive Officer, sanofi-aventis France ; President of LEEM Yann Le Cam, Chief Executive Officer of Eurordis, Vice Chair of the COMP at the EMEA Pierre Le Sourd, Chief Executive Officer, Bristo-Myers Squibb France Thomas London, Associate Director, McKinsey Thomas Lönngren, President of the European Medicine Agency Alex Matter, Director of the Novartis Institute of Tropical Disease Luc Montagnier, President of the World Foundation for AIDS Research & Prevention Stuart Schweitzer, Professor of Health Economics, UCLA School of Public Health Françoise Simon, Professor of Marketing, Columbia University Tomye Tierney, Vice-President, General Manager, Emerging markets, Genzyme Fred Turner, Chairman & Chief Executive Officer, Genzyme, France Willem Verhoofstad, Head of Project Management, Roche Christophe Weber, Senior Vice-President, GlaxoSmithKline Jean Zetlaoui, Vice-President, Portfolio Value Development, sanofi-aventis

Download the Chair brochure Press Videos Evaluation